Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo‐controlled clinical trial with inhaled loxapine
Joseph A. Kwentus, James V. Cassella(Trevi Therapeutics (United States)), Daniel A. Spyker(Alexza Pharmaceuticals (United States)), Raymond A Manning, Robert Fishman, John H. Kehne, Michael H. Allen(King's College London), Robert Riesenberg
Cited by 124
Related Papers
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
|Nature Genetics|2012|1k
Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
|The Lancet|2018|780
Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial
|The Lancet|2017|474
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
|European Respiratory Journal|2015|462
Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine
|The British Journal of Psychiatry|2011|153